A long-acting biologic with transmucosal transport properties that arrest SARS-CoV-2 virus variants
When the COVID-19 pandemic first started, no effective anti-viral drugs were available to fight the disease. However, in record time, so-called monoclonal antibodies were developed as a lifesaving treatment. Now, three years ...
Nov 29, 2023
0
65
